Inventor
JAMES HEYES
Inventor
CA
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
C12NMicroorganisms or enzymes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
B82YSpecific uses or applications of nanostructures6%
C07HSugars6%
C07JSteroids6%
Y02ATechnologies for adaptation to climate change6%
C07CAcyclic or carbocyclic compounds4%
C07DHeterocyclic compounds2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
12,357,705Negatively charged peg-lipid conjugates202512,350,383Cationic lipids containing silicon202512,251,470Lipid nanoparticle formulations202512,043,833Targeted compositions202412,016,929Lipid formulations for delivery of therapeutic agents202411,896,672Targeted nucleic acid conjugate compositions202411,786,598Lipid formulations for delivery of therapeutic agents202311,446,383Lipid formulations for delivery of therapeutic agents202211,427,823Targeted compositions202211,395,854Trialkyl cationic lipids and methods of use thereof202211,191,849Compositions and methods for delivering messenger RNA2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to ARBUTUS BIOPHARMA CORP (11)· patent assignee history
2021–2025Based in CA· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARBUTUS BIOPHARMA CORP | 11 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CA | 11 | 2021–2025 |